BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16293209)

  • 1. Mast cell and immune inhibitory receptors.
    Li L; Yao Z
    Cell Mol Immunol; 2004 Dec; 1(6):408-15. PubMed ID: 16293209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mast cell IgG receptors and their roles in tissue inflammation.
    Malbec O; Daëron M
    Immunol Rev; 2007 Jun; 217():206-21. PubMed ID: 17498061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
    Daëron M; Jaeger S; Du Pasquier L; Vivier E
    Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention?
    Ott VL; Cambier JC
    J Allergy Clin Immunol; 2000 Sep; 106(3):429-40. PubMed ID: 10984360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors.
    Katz HR
    Immunol Rev; 2007 Jun; 217():222-30. PubMed ID: 17498062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide.
    Izawa K; Yamanishi Y; Maehara A; Takahashi M; Isobe M; Ito S; Kaitani A; Matsukawa T; Matsuoka T; Nakahara F; Oki T; Kiyonari H; Abe T; Okumura K; Kitamura T; Kitaura J
    Immunity; 2012 Nov; 37(5):827-39. PubMed ID: 23123064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release.
    Tkaczyk C; Okayama Y; Metcalfe DD; Gilfillan AM
    Int Arch Allergy Immunol; 2004 Mar; 133(3):305-15. PubMed ID: 15017113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of leucocyte functions by CD33-related siglecs.
    Avril T; Attrill H; Zhang J; Raper A; Crocker PR
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A newly recognized pathway for the negative regulation of mast cell-dependent hypersensitivity and inflammation mediated by an endogenous cell surface receptor of the gp49 family.
    Katz HR; Austen KF
    J Immunol; 1997 Jun; 158(11):5065-70. PubMed ID: 9164917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.
    Masuda A; Nakamura A; Maeda T; Sakamoto Y; Takai T
    J Exp Med; 2007 Apr; 204(4):907-20. PubMed ID: 17420263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreceptor tyrosine-based inhibitory motifs on activating molecules.
    Sinclair NR
    Crit Rev Immunol; 2000; 20(2):89-102. PubMed ID: 10872892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.
    Tedla N; Lee CW; Borges L; Geczy CL; Arm JP
    J Leukoc Biol; 2008 Feb; 83(2):334-43. PubMed ID: 17998301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mast cell inhibitory receptors].
    Bąbolewska E; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():739-51. PubMed ID: 23175328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
    Kanazawa N
    J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we ready to downregulate mast cells?
    Karra L; Berent-Maoz B; Ben-Zimra M; Levi-Schaffer F
    Curr Opin Immunol; 2009 Dec; 21(6):708-14. PubMed ID: 19837574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory receptors and allergy.
    Katz HR
    Curr Opin Immunol; 2002 Dec; 14(6):698-704. PubMed ID: 12413518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells.
    Izawa K; Kitaura J; Yamanishi Y; Matsuoka T; Kaitani A; Sugiuchi M; Takahashi M; Maehara A; Enomoto Y; Oki T; Takai T; Kitamura T
    J Immunol; 2009 Jul; 183(2):925-36. PubMed ID: 19561101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory ITAMs: a matter of life and death.
    Pinheiro da Silva F; Aloulou M; Benhamou M; Monteiro RC
    Trends Immunol; 2008 Aug; 29(8):366-73. PubMed ID: 18602341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune inhibitory receptors.
    Ravetch JV; Lanier LL
    Science; 2000 Oct; 290(5489):84-9. PubMed ID: 11021804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative regulatory mechanisms in high-affinity IgE receptor-mediated mast cell activation.
    Roth K; Chen WM; Lin TJ
    Arch Immunol Ther Exp (Warsz); 2008; 56(6):385-99. PubMed ID: 19082920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.